EirGenix Inc. (TPE:6589)
51.30
+0.70 (1.38%)
Oct 8, 2026, 1:30 PM CST
EirGenix Market Cap
EirGenix has a market cap or net worth of 15.32 billion as of October 8, 2026. It is the 15,186th most valuable company in the world and the 548th biggest in Taiwan. Its market cap has decreased by 30.59% in one year.
Market Cap
15.32B
Enterprise Value
14.16B
Revenue
1.21B
Global Rank
Country Rank
#548 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 15.32B, an increase of 236.16%. That is a compound annual growth rate of 13.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 15.32B | -17.94% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 23.06B |
| Sunmax Biotechnology | 21.57B |
| Medigen Vaccine Biologics | 20.38B |
| TaiMed Biologics | 16.72B |
| Ever Supreme Bio Technology | 16.27B |
| ACRO Biomedical | 15.23B |
| Gongwin Biopharm Holdings | 14.41B |
| Lumosa Therapeutics | 13.62B |